Signature Equity Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.24K Sell
15
-2
-12% -$429 ﹤0.01% 1078
2026
Q1
$3.84K Sell
17
-105
-86% -$25.7K ﹤0.01% 1015
2025
Q4
$31K Buy
+122
New +$30.6K 0.02% 527

Other funds holding STE

Signature Equity Partners's STE Position: Q2 2026 in Review

Signature Equity Partners reduced its Steris (STE) stake by 12% in Q2 2026, selling an estimated $429 and leaving 15 shares worth $3.24K. The position accounts for ﹤0.01% of the portfolio, ranked #1078.

Signature Equity Partners first reported a position in STE in Q4 2025 and has held it in 3 quarters since. The position peaked at $31K in Q4 2025. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Signature Equity Partners held 15 shares of Steris worth $3.24K as of Q2 2026.
  • Signature Equity Partners sold 2 Steris shares in Q2 2026, an estimated $429.
  • Steris made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #1078 holding.
  • Signature Equity Partners first reported a position in Steris in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Steris position peaked at $31K in Q4 2025.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.